中国经济网北京9月22日讯 向日葵(300111.SZ)今日开盘涨停，截至发稿报5.95元，涨幅19.96%。9 月5日，公司股价收报4.96元，涨幅11.96%。 公司昨晚披露关于披露本次交易相关预案暨公司股票复牌及一般风险提示性的公告，公司拟以发行 股份及支付现金的方式购买漳州兮璞材料科技有限公司100%股权、浙江贝得药业有限公司40%股权并 募集配套资金。根据深交所相关规定，经公司申请，公司A股股票自2025年9月8日（星期一）上午开市 起停牌；经申请，公司股票将于2025年9月22日（星期一）上午开市起复牌。 | | | 单位:万元 | | --- | --- | --- | | 资产负债表项目 | 2024年12月31日 | 2023年12月31日 | | 资产总额 | 47.792.97 | 48,500.49 | | 负债总额 | 13.605.34 | 15.699.74 | | 所有者权益合计 | 34.187.63 | 32,800.75 | | 利润表项目 | 2024 年度 | 2023 年度 | | 营业收入 | 33.036.87 | 33.594.76 | | 营业利润 | 1, ...

截至2025年8月22日收盘，昂利康股价报50.56元，较前一交易日下跌1.56%。当日成交额达4.33亿元， 换手率为4.64%。 昂利康属于化学制药板块，公司主营业务为医药产品的研发、生产和销售。作为创新药概念股，公司产 品涵盖抗感染类、心血管类、消化系统类等多个治疗领域。 近期创新药行业迎来多项政策支持。国家医保局与卫健委7月初印发《支持创新药高质量发展的若干措 施》，提出增设商业健康保险创新药品目录，支持创新药进入医保目录和商业保险创新药品目录。此 外，创新药出海也取得进展，多家药企与跨国药企达成合作协议。 资金流向方面，8月22日昂利康主力资金净流入365.83万元，近五日主力资金净流入1.35亿元。 风险提示：股市有风险，投资需谨慎。 ...

Group 1 - As of August 21, 2025, Jiuzhou Pharmaceutical's stock price is 18.43 yuan, down 0.16 yuan or 0.86% from the previous trading day [1] - The trading volume on that day was 254,225 hands, with a transaction amount of 468 million yuan [1] - Jiuzhou Pharmaceutical focuses on the chemical pharmaceutical sector, primarily engaged in the research, production, and sales of active pharmaceutical ingredients and intermediates [1] Group 2 - The company's product range includes treatments for infections, cardiovascular diseases, and central nervous system disorders [1] - In the second quarter of 2025, the China-Europe Medical Health Fund reduced its holdings in Jiuzhou Pharmaceutical by 4.3884 million shares, although it remains one of the top ten circulating shareholders [1] - On August 21, 2025, the net outflow of main funds for Jiuzhou Pharmaceutical was 83.2752 million yuan, with a cumulative net outflow of 200 million yuan over the past five trading days [1]

Group 1 - On August 8, the stock price of Anglikang closed at 54.34 yuan, down 1.41 yuan or 2.53% from the previous trading day [1] - The opening price on the same day was 55.64 yuan, with a highest point of 57.25 yuan and a lowest point of 54.06 yuan, with a trading volume of 140,753 hands and a transaction amount of 777 million yuan [1] - Around 10:12 AM on August 8, Anglikang's stock price experienced a rapid rebound, increasing over 2% within 5 minutes, rising from 55.59 yuan to 56.1 yuan, with a transaction amount of 199 million yuan during this period [1] Group 2 - Anglikang operates in the chemical pharmaceutical industry, focusing on the research, production, and sales of pharmaceutical products [1] - The company's product range includes treatments for various fields such as anti-infection, cardiovascular, and digestive systems [1] Group 3 - On August 8, the net outflow of main funds was 49.57 million yuan, with a cumulative net outflow of 296 million yuan over the past five trading days [1]